Protein c derivatives
CA 2338799 A1 · Owner: Jones, Bryan Edward · Inventors: Jones, Bryan Edward; Gerlitz, Bruce Edward
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel protein C derivatives are described. These polypeptides retain the biological activity of the wild-type human protein C with substantially longer half-lives in human blood. These polypeptides will require either less frequent administration and/or smaller dosage than wild-type human protein C in the treatment of vascular occlusive disorders hypercoagulable states, thrombotic disorders and disease states predisposing to thrombosis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 13, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 13, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 13, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.